✦ LIBER ✦

906 EFFICACY OF 3 YEARS OF TELBIVUDINE TREATMENT FOR PATIENTS WITH GENOTYPE B/C CHRONIC HEPATITIS B (CHB)

✍ Scribed by Y.-C. Chen; C.-W. Hsu; Y.-F. Liaw; J. Jia; N. Leung; J. Hou; Y. Wang; Y. Chen; J. Niu; L.L. Wei; X.-Q. Zhou; W. Bao; P. Lopez

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of prolonged 3-year

✍ Edward J. Gane; Yuming Wang; Yun-Fan Liaw; JinLin Hou; Satawat Thongsawat; MoBin 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB

Durability of efficacy after telbivudine

✍ Chen, Da-biao; Chen, You-ming; Liu, Jing; Xie, Dong-ying; Lu, Cui-rong; Huang, Z 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 594 KB

Efficacy of switching to telbivudine in

✍ Rifaat Safadi; Qing Xie; Yagang Chen; You-Kuan Yin; Lai Wei; Seong Gyu Hwang; El 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

Telbivudine good value for patients with

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

539 2-YEAR RESULTS OF TELBIVUDINE (LDT)

✍ T. Piratvisuth; P. Komolmit; T. Tanwandee; W. Sukeepaisarnjaroen; H.L. Chan; M.G 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Kinetics of hepatitis B surface antigen

✍ Karsten Wursthorn; Mechthild Jung; Antonio Riva; Zachary D. Goodman; Patricia Lo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB